Open Access

Aptamer-Functionalized Fluorescent Silica Nanoparticles for Highly Sensitive Detection of Leukemia Cells

Contributed equally
Nanoscale Research Letters201611:298

Received: 6 May 2016

Accepted: 31 May 2016

Published: 14 June 2016


A simple, highly sensitive method to detect leukemia cells has been developed based on aptamer-modified fluorescent silica nanoparticles (FSNPs). In this strategy, the amine-labeled Sgc8 aptamer was conjugated to carboxyl-modified FSNPs via amide coupling between amino and carboxyl groups. Sensitivity and specificity of Sgc8-FSNPs were assessed using flow cytometry and fluorescence microscopy. These results showed that Sgc8-FSNPs detected leukemia cells with high sensitivity and specificity. Aptamer-modified FSNPs hold promise for sensitive and specific detection of leukemia cells. Changing the aptamer may allow the FSNPs to detect other types of cancer cells.


Ramos CellDetect Cancer CellReverse Microemulsion MethodHuman Acute Lymphoblastic LeukemiaAmide Coupling


Leukemia is a common, aggressive cancer that seriously affects blood cells, the lymphatic system, and the bone marrow [1, 2]. It seriously interferes with daily activities and increases the risk of death [3]. Immediate treatment is critical for improving the survival rate of patients with leukemia [4], highlighting the need for early diagnosis using sensitive and specific methods.

Current methods to detect leukemia cells usually rely on various cytochemical analyses of peripheral blood cells and bone marrow, including karyotyping [5], flow cytometry-based immunophenotyping [6], microarrays [7], cell enrichment [8], polymerase chain reaction [9], and electrochemical sensors [10]. These methods have various limitations, such as low sensitivity, high cost, and high complexity. Thus, a simple, highly sensitive method is urgently needed to detect leukemia cells.

A technology that shows promise in this regard is fluorescent silica nanoparticles (FSNPs), which are superior to organic dye probes [11]. FSNPs easily undergo surface modifications, and they show good biocompatibility [12]. On the other hand, FSNPs by themselves are not selective for cancerous tissue, so researchers have turned to aptamers to confer specificity and selectivity on FSNPs biodistribution and activity.

Aptamers are single-stranded nucleic acids selected from random-sequence libraries of DNA or RNA through an in vitro selection process called systematic evolution of ligands by exponential enrichment (SELEX) [13]. The resulting sequences can bind a wide range of targets with high affinity, including small molecules [14, 15], proteins [16], and even whole cells [17]. Numerous studies have shown that aptamer-functionalized FSNPs can target many types of cancer [1820]. These results suggest that aptamer-FSNPs may allow reliable identification of leukemia cells.

Here, we design and prepare FSNPs modified with the aptamer Sgc8, which binds tightly and specifically to T acute lymphocytic leukemia cells. The resulting Sgc8-FSNPs were analyzed by dynamic light scattering, transmission electron microscopy (TEM), zeta potential measurement, Fourier transform infrared (FT-IR) spectroscopy, ultraviolet–visible (UV–vis) spectroscopy, and fluorimetry. Their ability to detect leukemia cells was assessed using flow cytometry and fluorescence microscopy. Their toxicity was evaluated in vitro and in vivo using the CKK-8 assay and histology of organ sections. Our results suggest that this novel probe may be a reliable and efficient way to detect leukemia cells.



Fluorescein isothiocyanate (FITC), 3-aminopropylmethyldimethoxysilane (APTMS), Triton X-100, n-hexanol, cyclohexane, tetraethyl orthosilicate (TEOS), ammonium hydroxide (NH4OH, 25-28 wt %), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC), N-hydroxysulfosuccinimide sodium salt (sulfo-NHS), and N-[(3-trimethoxysilyl)propyl]ethylenediamine triacetic acid trisodium salt (TMS-EDTA) were bought from Sigma Chemical (St. Louis, MO, USA). DNA oligonucleotides were synthesized by Shanghai Sangon Biological Engineering Technology & Services (Shanghai, China). These oligonucleotides included the amine-labeled Sgc8 aptamer (Sgc8), 5′-NH2-TTTTTTTTTTATCTAACTGCTGCGCCGCCGGGAAAATACTGTACGGTTAGA-3′; and amine- and FITC-labeled Sgc8 (FITC-Sgc8), 5′-NH2-TTTTTTTTTTATCTAACTGCTGCGCCGCCGGGAAAATACTGTACGGTTAGA-FITC-3′.

Preparation of Sgc8-FSNPs

A mixture of FITC in anhydrous ethanol (1 mg/l, 1 ml) and APTMS (10 μl) was stirred for 24 h to prepare FITC-APTMS. FSNPs were prepared as a water-in-oil microemulsion in a solution containing 7.5 ml of cyclohexane, 1.6 ml of n-hexanol, 1.77 ml of Triton X-100, and 500 μl of distilled water. This solution was stirred for 30 min at room temperature, and then 150 μl of FITC-APTMS, 100 μl of TEOS, and 60 μl of NH4OH were successively added, after which the solution was stirred for another 24 h. Then 30 μl of NTTS was added, and the mixture was stirred for another 24 h. The resulting carboxyl-modified FSNPs (FSNPs-COOH) were precipitated in an equal volume of acetone and collected by alternately centrifuging and washing three times with deionized water and fresh 95 % ethanol.

Amine-labeled Sgc8 was cross-linked to FSNPs-COOH using EDC as follows. Briefly, FSNPs-COOH (ca. 0.1 mg, 1 ml) were washed in MES buffer (0.1 M, pH 5.65) and resuspended in 950 μl of MES buffer (0.1 M, pH 5.65). This solution was added with 50 μl of 10 μM amine-labeled Sgc8, 1.8 mg of EDC, and 3.5 mg of sulfo-NHS, after which the mixture was shaken gently for 3 h at room temperature. The nanoparticles were washed three times with PBS (0.1 M, pH 7.4) and incubated with 0.05 % BSA in PBS for 1 h at room temperature to block free carboxyl groups. Sgc8-FSNPs were collected by three rounds of centrifugation and resuspension in PBS and then stored at 4 °C in MES buffer (0.1 M, pH 5.65) containing 1 % BSA until use.

Characterization of Sgc8-FSNPs

The structural features of Sgc8-FSNPs were analyzed using TEM (H-7650, Japan), while average size and zeta potential were determined using dynamic light scattering on a Zetasizer Nano instrument (Malvern Instruments, UK). The modification of surface carboxyl and amino groups on FSNPs was confirmed using FT-IR spectroscopy (Nicolet-5700, USA). The UV–vis absorption spectrum was obtained (UV 2550, Shimadzu, Japan), as well as fluorescence emission spectrum (Hitachi F-4600, Japan). For all these measurements, a concentration of 0.1 mg/ml Sgc8-FSNPs was used.

The number of moles of FSNPs was calculated using the method of Pang et al. [12], and the average number of aptamers on the nanoparticle surface was estimated based on fluorescence signal as follows. Briefly, initial fluorescence intensity (I 1) was measured immediately after mixing FITC-Sgc8 with FSNPs-COOH. When amide coupling of FITC-Sgc8 to FSNPs-COOH via the carboxyl and amino groups was complete, the supernatant was washed to remove unbound FITC-Sgc8, and the fluorescence intensity (I 2) of the resuspension was measured. The ratio I 2/I 1 was taken to indicate the efficiency of aptamer modification on the surface of FSNPs. Then the amount of Sgc8 on FSNPs was calculated by taking the actual number of FITC-Sgc8 molecules on FSNPs and dividing by the number of FSNPs.

Cells and Animals

Cell lines were obtained from the National Center for International Research of Biological Targeting Diagnosis and Therapy of Guangxi Medical University. CCRF-CEM cells (human acute lymphoblastic leukemia, T cell) as a positive control for leukemia cells and Ramos cells (human Burkitt’s lymphoma, B cell) as a negative control were cultured in 1640 medium supplemented with 10 % fetal bovine serum (FBS, Hyclone) and 100 U/ml penicillin-streptomycin. Both cell lines were incubated with Sgc8-FSNPs. In a separate experiment, L-02 and 293T cells were incubated with Sgc8-FSNPs to evaluate their cytotoxicity. These two cell lines were cultured in DMEM medium supplemented with 10 % FBS and 100 U/ml penicillin-streptomycin.

Six-week-old female BALB/c nude mice from the Guangxi Laboratory Animal Center (Guangxi, China) were raised in sterile conditions in a laminar flow hood. All protocols were conducted in accordance with the guidelines of the Animal Ethics Committee of Guangxi Medical University, Nanning, Guangxi, China.

Flow Cytometry

Cells were cultured at a density of 3.0 × 105 cells/ml, collected by centrifugation, and resuspended in 200 μl of PBS. Then cells were incubated on ice for 30 min in the dark with Sgc8-FSNPs, FSNPs, or FITC-Sgc8 in 200 μl of cell culture medium or binding buffer (PBS supplemented with 5 mM MgCl2, 4.5 g/l glucose, and 1 mg/ml BSA). Cells were washed with PBS, suspended in 200 μl of binding buffer and analyzed by flow cytometry (Beckman Coulter Epics XL, USA). Data were analyzed using EXPO32 ADC Analysis software.

Cell Imaging

CCRF-CEM and Ramos cells were cultured for 12 h in six-well dishes at a density of 3 × 105 cells per well. Cells were washed three times with PBS and incubated with Sgc8-FSNPs, FSNPs, or FITC-Sgc8, respectively, in binding buffer on ice for 30 min in the dark. Cells were washed three times with PBS, fixed with 4 % polyoxymethylene (Sigma-Aldrich) for 20 min, and stained with 4′, 6-diamidino-2-phenylindole dihydrochloride (DAPI; Life Co., USA) for 5 min in the dark. Finally, cells were washed three times with PBS and examined by fluorescence microscopy (Nikon DS-Ri1, Japan).

In Vitro and In Vivo Toxicity of Sgc8-FSNPs

Two types of normal cells, such as L-02 and 293T cells, were cultured for 24 h in 96-well plates at an initial density of 1.0 × 104 cells/well and then exposed to Sgc8-FSNPs at 0.1, 0.5, or 1.0 mg/ml for 8, 16, and 24 h. Cytotoxicity of the treatments was assessed using the CCK-8 assay [21]. At the specific time points, the culture medium was removed and cells were washed three times with PBS. Then 10 μl of CCK-8 solution was added to each well in 90 μl of serum-free DMEM medium. After incubation for 4 h at 37 °C, the absorbance of each well at 450 nm was measured using a Bio-Rad microplate reader (DTX880, Beckman Coulter, USA).

To examine the in vivo toxicity of Sgc8-FSNPs, nude mice received a single tail vein injection of 200 μl of PBS (control group) or PBS containing Sgc8-FSNPs, FSNPs, or FITC-Sgc8 (1 mg/ml). At 1 week after injection, mice were sacrificed, and sections of major tissues (heart, lung, liver, spleen, kidney) were immersed in 10 % formaldehyde solution, dehydrated, and paraffin-embedded. Serial sections (4 μm) were cut and stained with hematoxylin-eosin.

Statistical Analyses

Each experiment was carried out in triplicate. Data were expressed as mean ± SD or as median (range). All statistical analyses were performed using GraphPad Prism (GraphPad Software, San Diego, CA, USA). P < 0.05 was considered the threshold of significance in all analyses.

Results and Discussion

In this present study, we combined the Sgc8 aptamer, developed through live-cell SELEX to bind tightly and specifically to CCRF-CEM cells [22], with FSNPs as a signal reporter in order to develop a novel detection probe for leukemia (Fig. 1). The combination of specific targeting by Sgc8 and the strong fluorescence, photostability, and biocompatibility of FSNPs [11] may make Sgc8-FSNPs a clinically useful reagent in the fight to diagnose leukemia as early as possible to ensure timely treatment.
Fig. 1

Schematic illustration of Sgc8 aptamer-modified FSNPs for highly sensitive detection of leukemia cells

Characterization of Sgc8-FSNPs

The reverse microemulsion method is widely used to prepare silica nanoparticles, because it can yield uniform, monodisperse particles [23], and our FSNPs were indeed uniform in shape and size (Fig. 2a, panels a and b). Average diameter was 70.52 ± 2.64 nm for FSNPs and 75.18 ± 2.89 nm for Sgc8-FSNPs; the corresponding zeta potentials were −31.21 ± 2.75 mV and −37.57 ± 3.33 mV (Table 1). The more negative zeta potential for Sgc8-FSNPs than FSNPs (Fig. 2b) likely reflects the additional negative charge of the phosphate groups on the DNA aptamer [24]. The efficiency of aptamer conjugation onto the surface of FSNPs was determined indirectly from the change in fluorescence intensity during the reaction between FITC-Sgc8 and SNPs. Based on the conversion that 1 mg of SNPs with an average diameter of about 60 nm is approximately 6.8 pmol [12], and assuming that the initial number of aptamers was 500 pmol and the conjugation efficiency was 43 %, we estimated that the surface of our FSNPs contained approximately 420 aptamers (Table 1).
Fig. 2

Characterization of Sgc8-FSNPs. a Particle size distribution of a Sgc8-FSNPs based on dynamic light scattering. b TEM of Sgc8-FSNPs. b Zeta potential of Sgc8, FSNPs, and Sgc8-FSNPs. c FT-IR spectra of Sgc8, FSNPs, and Sgc8-FSNPs. d UV–vis absorbance (solid line) and fluorescence emission spectra (dashed line) of FSNPs before and after modification with Sgc8

Table 1

Size, zeta potential, and surface charge characteristics of FSNPs and Sgc8-FSNPs


Size (nm)

Zeta (mV)



70.52 ± 2.64

−31.21 ± 2.75


75.18 ± 2.89

−37.57 ± 3.33

419.92 ± 39.83

The FT-IR spectra of Sgc8, FSNPs, and Sgc8-FSNPs are shown in Fig. 2c. The spectrum for Sgc8-FSNPs showed peaks at 1658 cm−1 (C=O carbonyl stretching vibrations), 1554 cm−1 (C–N stretching vibrations and N–H bending), and 1100 cm−1 (Si–O stretching vibrations). The feature of amides II was observed around 1554 cm−1 originated from C–N stretching vibrations and N–H bending [25]. The peak at 1554 cm−1 was observed at the spectrum for Sgc8-FSNPs, so it likely reflects the attachment of the amine-labeled aptamer Sgc8 to the surface of FSNPs-COOH.

Figure 2d shows the UV–vis absorbance spectrum (solid line) and fluorescence emission spectrum (dashed line) of FSNPs before and after aptamer conjugation. The UV–vis spectrum of Sgc8-FSNPs showed a DNA absorbance peak at 260 nm that was absent from the spectrum of FSNPs, suggesting that the aptamer had indeed conjugated with the nanoparticles. The fluorescence emission spectra of both FSNPs and Sgc8-FSNPs showed a peak at 520 nm, corresponding to FITC. This indicates that aptamer addition does not change the fluorescence properties of FSNPs [26].

These results of characterization of Sgc8-FSNPs indicate that we successfully conjugated aptamer to the surface of FSNPs.

Flow Cytometric Detection of Leukemia Cells

At first, the ability of Sgc8-FSNPs to detect leukemia cells was investigated by flow cytometry. Ramos cells were used as negative cells, and FSNPs were used as control probe. For the detection of CCRF-CEM cells, stronger fluorescence intensity was observed on Sgc8-FSNPs than FITC-Sgc8, while no fluorescence signal was found on FSNPs (Fig. 3a, panel a). In addition, no obvious fluorescence signal was observed on Ramos cells after incubation with Sgc8-FSNPs, FITC-Sgc8, and FSNPs, respectively (Fig. 3a, panel b). Similar results were obtained by statistical graph of the binding rate of CEM and Ramos cells (Fig. 3b, panels a and b). These results suggested that Sgc8-FSNPs can be used to detect CEM cells with higher sensitivity than FITC-Sgc8.
Fig. 3

Flow cytometric detection of leukemia cells. a Sgc8-FSNPs, FITC-Sgc8, or FSNPs were mixed with a CCRF-CEM cells or b Ramos cells. b Statistical graph for rates of binding to a CCRF-CEM cells and b Ramos cells by Sgc8-FSNPs, FITC-Sgc8, or FSNPs. NS, not significant. **P < 0.01, ***P < 0.001

Fluorescence Microscopy

To confirm whether the synthesized Sgc8-FSNPs can recognize and bind CEM cells, fluorescence microscopy images were performed with the same brightness and contrast. As shown in Fig. 4a, both Sgc8-FSNPs and FITC-Sgc8 stained surface of CCRF-CEM cells with green fluorescence, while FSNPs did not. Stronger green fluorescence was also observed on Sgc8-FSNPs than FITC-Sgc8 (Fig. 4a). Consistent with the analysis of flow cytometry, no green fluorescence was found on the surface of Ramos cells after incubation with Sgc8-FSNPs, FITC-Sgc8, and FSNPs, respectively (Fig. 4b). So, we can agree that Sgc8-FSNPs specially recognize and bind CEM with high sensitivity, which is attributed to the interaction between aptamer and its targeting cells rather than the nonspecific binding between FSNPs and cells. In addition, the fluorescence signal of Sgc8-FSNPs is stronger than FITC-Sgc8, which is caused by fluorescent signal amplification of FSNPs.
Fig. 4

Fluorescence micrographs of CCRF-CEM and Ramos cells after mixing with Sgc8-FSNPs, FITC-Sgc8, or FSNPs. a CCRF-CEM cells after incubation. b Ramos cells after incubation. Nuclei were stained with DAPI and examined in the blue channel, while FSNPs and FITC were examined in the green channel. The blue and green channels were combined in the merged images

Photostability of Sgc8-FSNPs and FITC-Sgc8

To confirm the anti-photobleaching property of FITC dyes doped inside the silica matrix, fluorescence microscopy was also used to assess the photostability of Sgc8-FSNPs and FITC-Sgc8. Samples were illuminated continuously with a 488-nm laser for 10 min, and fluorescent images were taken at 0, 1, 5, and 10 min. Fluorescence intensity was quantitated using Image Pro (Media Cybernetics, Bethesda, MD, USA). Fluorescence intensity was stronger for Sgc8-FSNPs than for FITC-Sgc8. Normalized fluorescence intensity was also compared between Sgc8-FSNPs and FITC-Sgc8. Intense irradiation for 10 min reduced the fluorescence intensity of Sgc8-FSNPs by only 18 %, while the fluorescence intensity of FITC-Sgc8 fell by 74 %. This suggests that Sgc8-FSNPs were more photostable than FITC-Sgc8. The reason may be explained by FITC molecules well doped the silica shell that separate potential quenching substance from dye molecules through electrostatic interaction [12, 2729] (Fig. 5).
Fig. 5

Fluorescence images and quantitation of photostability of Sgc8-FSNPs and FITC-Sgc8

In Vitro and In Vivo Toxicity of Sgc8-FSNPs

In vitro cytotoxicity of Sgc8-FSNPs was evaluated in the normal cell lines 293T and L-02. Both cell lines showed high viability, based on the CCK-8 assay, after incubation with various concentrations of Sgc8-FSNPs (Fig. 6a, panels a and b). This suggests that Sgc8-FSNPs show minimal cytotoxicity. We tested this in vivo by treating nude mice with Sgc8-FSNPs and then examining tissue sections from major organs after staining with hematoxylin-eosin. No obvious signs of necrosis or inflammation were observed, confirming that Sgc8-FSNPs show minimal toxic effects (Fig. 6b). This justifies further animal and potentially human testing of Sgc8-FSNPs as a diagnostic probe in the clinic. However, FSNPs show short half-life in the circulatory system, the aptamer is vulnerable to degradation, and the release of fluorescent dye into the blood may increase the risk of systemic toxicity [18]. So, further studies should minimize these limitations for in vivo biological applications.
Fig. 6

Cell and tissue toxicity tests of Sgc8-FSNPs. a a 293T and b L-02 cells were treated with various concentrations of Sgc8-FSNPs, and cell viability was measured every 8 h. b Nude mice were treated with PBS or Sgc8-FSNPs, and sections from major organs were stained with hematoxylin-eosin and examined by light microscopy

Our work adds to a growing literature demonstrating the power of aptamer-nanoparticles conjugation for the detection and treatment of cancer. Such conjugates have been used to collect and image leukemia cells [30], detect cancer cells in whole blood [31], create a “super sandwich” cytosensor of aptamer-quantum dots to detect cancer cells [32], target and deliver daunorubicin to leukemia cells [33], and target CEM cells for controlled drug delivery [34]. The present study extends this literature by determining the amount of aptamer on nanoparticles, showing sensitive and specific detection of CCRF-CEM cells over Ramos cells, and evaluating the in vivo toxicity of Sgc8-FSNPs.


In summary, we have designed a simple, highly sensitive, and specific aptamer-modified FSNPs system for detecting leukemia cells. The usefulness of this system lies in the strong, specific target binding by the aptamer, as well as the fluorescence signal amplification due to the high density of FITC fluorophore in the nanoparticles. This system may prove useful not only for the diagnosis of leukemia but also for the targeted delivery of anti-leukemia drugs. In addition, it may be adaptable to other types of cancer through the selection of appropriate aptamers.





1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride


fluorescein isothiocyanate


fluorescent silica nanoparticles


Fourier transform infrared


ammonium hydroxide


Sc8 aptamer


N-hydroxysulfosuccinimide sodium salt


transmission electron microscopy


tetraethyl orthosilicate





The authors thank the support of the Key Project of the National Natural Science Foundation of China (No. 81430055), Project of the National Natural Science Foundation of China (Nos. 81372362 and 81360335), and Program for Changjiang Scholars and Innovative Research Team in the University of Ministry of Education of China (No. IRT_15R13).

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

National Center for International Research of Biological Targeting Diagnosis and Therapy, Guangxi Key Laboratory of Biological Targeting Diagnosis and Therapy Research, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, China
Department of Oncologic Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China
Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
Department of Thoracic Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China


  1. Foon KA, Todd RF 3rd (1986) Immunologic classification of leukemia and lymphoma. Blood 68:1–31Google Scholar
  2. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29View ArticleGoogle Scholar
  3. Dietrich M, Rasche H, Rommel K, Hochapfel G (1973) Antimicrobial therapy as a part of the decontamination procedures for patients with acute leukemia. Eur J Cancer 9:443–447View ArticleGoogle Scholar
  4. Breems DA, Van Putten WL, De Greef GE, Van Zelderen-Bhola SL, Gerssen-Schoorl KB, Mellink CH, Nieuwint A, Jotterand M, Hagemeijer A, Beverloo HB, Lowenberg B (2008) Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol 26:4791–4797View ArticleGoogle Scholar
  5. Faderl S, Kantarjian HM, Talpaz M, Estrov Z (1998) Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood 91:3995–4019Google Scholar
  6. Paredes-Aguilera R, Romero-Guzman L, Lopez-Santiago N, Burbano-Ceron L, Camacho-Del Monte O, Nieto-Martinez S (2001) Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia. Am J Hematol 68:69–74View ArticleGoogle Scholar
  7. Belov L, de la Vega O, dos Remedios CG, Mulligan SP, Christopherson RI (2001) Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Res 61:4483–4489Google Scholar
  8. Paterlini-Brechot P, Benali NL (2007) Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 253:180–204, Epub 2007 Feb 2020View ArticleGoogle Scholar
  9. Ghossein RA, Bhattacharya S (2000) Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours. Eur J Cancer 36:1681–1694View ArticleGoogle Scholar
  10. Li JJ, Xi Q, Du WF, Yu RQ, Jiang JH (2016) Label-free fluorescence detection of microRNA based on target induced adenosine2-coralyne-adenosine2 formation. Analyst 141:2384–2387View ArticleGoogle Scholar
  11. Estevez MC, Huang YF, Kang H, O'Donoghue MB, Bamrungsap S, Yan J, Chen X, Tan W (2010) Nanoparticle-aptamer conjugates for cancer cell targeting and detection. Methods Mol Biol 624:235–248View ArticleGoogle Scholar
  12. Cai L, Chen ZZ, Chen MY, Tang HW, Pang DW (2013) MUC-1 aptamer-conjugated dye-doped silica nanoparticles for MCF-7 cells detection. Biomaterials 34:371–381View ArticleGoogle Scholar
  13. Wu Y, Sefah K, Liu H, Wang R, Tan W (2010) DNA aptamer-micelle as an efficient detection/delivery vehicle toward cancer cells. Proc Natl Acad Sci U S A 107:5–10View ArticleGoogle Scholar
  14. Bagalkot V, Farokhzad OC, Langer R, Jon S (2006) An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed Engl 45:8149–8152View ArticleGoogle Scholar
  15. Yu JG, Zhao XH, Yu LY, Yang H, Chen XQ, Jiang JH (2014) Fluorescent probes for selective probing thiol-containing amino acids. Curr Org Synth 11:377–402View ArticleGoogle Scholar
  16. Gelinas AD, Davies DR, Janjic N (2016) Embracing proteins: structural themes in aptamer-protein complexes. Curr Opin Struct Biol 36:122–132View ArticleGoogle Scholar
  17. Dwivedi HP, Smiley RD, Jaykus LA (2013) Selection of DNA aptamers for capture and detection of Salmonella Typhimurium using a whole-cell SELEX approach in conjunction with cell sorting. Appl Microbiol Biotechnol 97:3677–3686View ArticleGoogle Scholar
  18. Jo H, Her J, Ban C (2015) Dual aptamer-functionalized silica nanoparticles for the highly sensitive detection of breast cancer. Biosens Bioelectron 71:129–136View ArticleGoogle Scholar
  19. Estévez MC, O’Donoghue MB, Chen X, Tan W (2010) Highly fluorescent dye-doped silica nanoparticles increase flow cytometry sensitivity for cancer cell monitoring. Nano Res 2:448–461View ArticleGoogle Scholar
  20. Xie X, Li F, Zhang H, Lu Y, Lian S, Lin H, Gao Y, Jia L (2016) EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. Eur J Pharm Sci 83:28–35View ArticleGoogle Scholar
  21. Yue H, Wei W, Yue Z, Wang B, Luo N, Gao Y, Ma D, Ma G, Su Z (2012) The role of the lateral dimension of graphene oxide in the regulation of cellular responses. Biomaterials 33:4013–4021View ArticleGoogle Scholar
  22. Shangguan D, Li Y, Tang Z, Cao ZC, Chen HW, Mallikaratchy P, Sefah K, Yang CJ, Tan W (2006) Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A 103:11838–11843View ArticleGoogle Scholar
  23. Bagwe RP, Yang C, Hilliard LR, Tan W (2004) Optimization of dye-doped silica nanoparticles prepared using a reverse microemulsion method. Langmuir 20:8336–8342View ArticleGoogle Scholar
  24. Ho HA, Leclerc M (2004) Optical sensors based on hybrid aptamer/conjugated polymer complexes. J Am Chem Soc 126:1384–1387View ArticleGoogle Scholar
  25. Fahmy K, Jager F, Beck M, Zvyaga TA, Sakmar TP, Siebert F (1993) Protonation states of membrane-embedded carboxylic acid groups in rhodopsin and metarhodopsin II: a Fourier-transform infrared spectroscopy study of site-directed mutants. Proc Natl Acad Sci U S A 90:10206–10210View ArticleGoogle Scholar
  26. Li H, Guo L, Huang A, Xu H, Liu X, Ding H, Dong J, Li J, Wang C, Su X, Ge X, Sun L, Bai C, Shen X, Fang T, Li Z, Zhou Y, Zhan L, Li S, Xie J, Shao N (2015) Nanoparticle-conjugated aptamer targeting hnRNP A2/B1 can recognize multiple tumor cells and inhibit their proliferation. Biomaterials 63:168–176View ArticleGoogle Scholar
  27. Liu A, Wu L, He Z, Zhou J (2011) Development of highly fluorescent silica nanoparticles chemically doped with organic dye for sensitive DNA microarray detection. Anal Bioanal Chem 401:2003–2011View ArticleGoogle Scholar
  28. Burns A, Sengupta P, Zedayko T, Baird B, Wiesner U (2006) Core/shell fluorescent silica nanoparticles for chemical sensing: towards single-particle laboratories. Small 2:723–726View ArticleGoogle Scholar
  29. Auger A, Samuel J, Poncelet O, Raccurt O (2011) A comparative study of non-covalent encapsulation methods for organic dyes into silica nanoparticles. Nanoscale Res Lett 6:328View ArticleGoogle Scholar
  30. Smith JE, Medley CD, Tang Z, Shangguan D, Lofton C, Tan W (2007) Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells. Anal Chem 79:3075–3082View ArticleGoogle Scholar
  31. Deng T, Li J, Zhang LL, Jiang JH, Chen JN, Shen GL, Yu RQ (2010) A sensitive fluorescence anisotropy method for the direct detection of cancer cells in whole blood based on aptamer-conjugated near-infrared fluorescent nanoparticles. Biosens Bioelectron 25:1587–1591View ArticleGoogle Scholar
  32. Liu H, Xu S, He Z, Deng A, Zhu JJ (2013) Supersandwich cytosensor for selective and ultrasensitive detection of cancer cells using aptamer-DNA concatamer-quantum dots probes. Anal Chem 85:3385–3392View ArticleGoogle Scholar
  33. Danesh NM, Lavaee P, Ramezani M, Abnous K, Taghdisi SM (2015) Targeted and controlled release delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer-modified gold nanoparticles. Int J Pharm 489:311–317View ArticleGoogle Scholar
  34. Liu C, Zheng J, Deng L, Ma C, Li J, Li Y, Yang S, Yang J, Wang J, Yang R (2015) Targeted intracellular controlled drug delivery and tumor therapy through in situ forming Ag nanogates on mesoporous silica nanocontainers. ACS Appl Mater Interfaces 7:11930–11938View ArticleGoogle Scholar


© The Author(s). 2016